Multiplikator Forward P/S: cbdMD, Inc. (YCBD)
The growth dynamics of cbdMD, Inc. (YCBD) are based on the creation of a closed subscription ecosystem for wellness products, as confirmed by the forward P/S history. The current level of this metric is 0.20. Growth is supported by the recruitment of top marketers into the fast-growing supplements sector. Simultaneously, cbdMD, Inc. (YCBD) is implementing an eco-friendly approach, optimizing packaging and warehouse energy costs to improve raw material quality.
cbdmd.com - rincian analitis lan metrik utama (YCBD)
- rega saiki lan proyeksi nilai saham:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- rincian struktur utang lan likuiditas bisnis:
Total Utang marang Modal cbdMD, Inc.|YCBD - Rasio utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas cbdMD|YCBD - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku cbdMD, Inc.|YCBD - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan cbdMD|Rasio cepet cbdmd.com
- rincian asil keuangan lan kelipatan valuasi:
YCBD - Penghasilan resik|Bathi mangsa ngarep cbdMD, Inc.|YCBD - Periode bali modal bisnis|Prakiraan rega marang bathi cbdMD|YCBD - Rega marang bathi kanthi panyesuaian wutah|Pangali EV/EBITDA cbdMD, Inc.|YCBD - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) cbdMD|YCBD - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan cbdmd.com|YCBD - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep cbdMD, Inc.
- indikator dodolan lan pendapatan:
Ringkesan analisis perusahaan:cbdMD Corp YCBD
The stable capacity utilization of cbdMD, Inc. partner plants producing CBD products allows for the correlation of the company's current market value with projected future sales via the forward P/S ratio. It is critical for investors to monitor this indicator, as it measures the efficiency of production capacity monetization, turning the trend of this forward P/S valuation into a signal of whether the asset is undervalued or overheated.
Analisis perusahaan pesaing
Multiplikator Forward P/S HLN (Haleon)|KVUE - Multiplikator forward rega marang pendapatan|Verona Pharma Corp - Multiplikator Forward P/S|MENS: Rasio rega marang prakiraan pendapatan|LGND: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan AMRX|Rasio rega marang prakiraan pendapatan Perrigo|Multiplikator forward rega marang pendapatan Alvotech S.A. (ALVO)|Multiplikator Forward P/S LQDA|Galapagos Corp - Kapitalisasi marang prakiraan pendapatan|ANI Pharmaceuticals - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan MNKD|Amphastar Pharmaceuticals, Inc. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Pacira Pharmaceuticals PCRX|ARS Pharma (SPRY) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan TBPH|AQST (Aquestive Therapeutics) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan scPharma (SCPH)|Multiplikator forward rega marang pendapatan TECX (Tectonic Therapeutic, Inc.)|Rasio kapitalisasi marang dodolan sing dikarepake Tonix Pharma|China SXT Pharmaceuticals, Inc. - Multiplikator forward rega marang pendapatan|Eupraxia Pharmaceuticals, Inc. (EPRX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|BioHarvest Sciences - Multiplikator Forward P/S|invizyne.com (EXOZ) - Multiplikator forward rega marang pendapatan|ORMP: Multiplikator Forward P/S|ENTX (Entera Bio) - Rasio rega marang prakiraan pendapatan|HYFT (MindWalk) - Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan ABVC (ABVC BioPharma, Inc)|Rasio rega marang prakiraan pendapatan Cumberland Pharmaceuticals (CPIX)|QNTM: Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S FGEN (FibroGen)|Rega forward marang dodolan TELO|Rani Therapeutics Inc - Multiplikator Forward P/S|SNYR - Multiplikator Forward P/S|rallybio.com (RLYB) - Rasio rega marang prakiraan pendapatan|Lexaria Bioscience Corp. - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Pulmatrix|Multiplikator forward rega marang pendapatan Pheton (PTHL)|Multiplikator Forward P/S APM|Multiplikator Forward P/S Lyra Therapeutics Inc (LYRA)|Impact BioMedical Inc - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan TNFA|PRFX - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Altamira Therapeutics|LIPO (Lipella) - Multiplikator forward rega marang pendapatan|OPTN: Rasio rega marang pendapatan sing dikarepake|PIRS (Pieris Pharmaceuticals) - Multiplikator Forward P/S|PROC: Rega forward marang dodolan|Multiplikator Forward P/S PTPI|QLI - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan ACELYRIN, Inc. SLRN|Rega forward marang dodolan TFFP
